Bharat Biotech completes phase 3 trial of intranasal Covid vaccine
New Delhi, Aug 16: Bharat Biotech has completed the clinical development for phase III trials and booster doses for the intranasal Covid-19 vaccine. Bharat Biotech – the manufacturer of Covid-19 vaccine Covaxin – said that its COVID-19 intranasal vaccine (BBV154) has
Source: India News, India Breaking News, Latest news headlines in India – Oneindia News